Examination of Postdural Puncture Headache Frequency, Predisposing Factors and Treatment
NCT ID: NCT06394024
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2023-11-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sphenopalatine Ganglion Block Versus Occiptal Nerve Block in Treatment of Post Dural Puncture Headache
NCT03156049
Sphenopalatine Block Versus Greater Occipital Nerve Block in PDPH
NCT05235256
Optic Nerve Sheath Diameter in Postspinal Headache
NCT06957899
Trans-nasal Sphenopalatine Ganglion Block Versus Ultrasound-guided Bilateral Greater and Lesser Occipital Nerve Block for Management of Post-Dural Puncture Headache.
NCT06705244
Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache
NCT04844229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
POSTDURAL PUNCTURE HEADHECHE
We don't use drug
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status class I, II and III
* BMI \<40 kg/m²
* Patients undergoing spinal anesthesia
Exclusion Criteria
* Severe cardiac, respiratory, hepatic, and renal disease
* Refusing spinal anesthesia
* History of local anesthetic allergy
* Localized infection at the injection site
* Coagulopathy
* Anticoagulant drugs usage
* History of chronic pain (migraine, sinusitis, etc.)
* Alcohol and opioid addiction
* Psychiatric diseases
* Communication difficulties
* Vertebral or chest wall abnormalities
* BMI \> 40 kg/m²
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Soner Ozcan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Soner Ozcan
medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa Soner Mustafa Soner
Role: PRINCIPAL_INVESTIGATOR
Suleyman Demirel University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suleyman Demirel University
Isparta, Isparta, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
İLK-10-124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.